Ke Geng

835 total citations
15 papers, 530 citations indexed

About

Ke Geng is a scholar working on Immunology, Physiology and Infectious Diseases. According to data from OpenAlex, Ke Geng has authored 15 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Physiology and 3 papers in Infectious Diseases. Recurrent topics in Ke Geng's work include Phagocytosis and Immune Regulation (8 papers), Erythrocyte Function and Pathophysiology (4 papers) and Immune Cell Function and Interaction (3 papers). Ke Geng is often cited by papers focused on Phagocytosis and Immune Regulation (8 papers), Erythrocyte Function and Pathophysiology (4 papers) and Immune Cell Function and Interaction (3 papers). Ke Geng collaborates with scholars based in United States, China and Hong Kong. Ke Geng's co-authors include Raymond B. Birge, Canan Kasikara, Sushil Kumar, Sergei V. Kotenko, Viralkumar Davra, Stanley Kimani, Ganapathy Sriram, Mariana S. De Lorenzo, Michael Wichroski and Michael Quigley and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Science Advances.

In The Last Decade

Ke Geng

14 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Geng United States 11 393 143 139 80 52 15 530
Kristen M. Jacobsen United States 9 336 0.9× 154 1.1× 98 0.7× 70 0.9× 59 1.1× 14 597
Serena Lofftus United States 7 460 1.2× 127 0.9× 114 0.8× 41 0.5× 70 1.3× 14 628
Diana C. Contreras United States 8 289 0.7× 179 1.3× 110 0.8× 49 0.6× 29 0.6× 11 500
Andreas Kislat Germany 8 162 0.4× 101 0.7× 137 1.0× 117 1.5× 26 0.5× 14 481
Wonyong Lee South Korea 11 361 0.9× 173 1.2× 107 0.8× 52 0.7× 46 0.9× 18 551
Eui‐Young So United States 12 163 0.4× 152 1.1× 96 0.7× 53 0.7× 27 0.5× 17 397
Avishai Shemesh United States 15 469 1.2× 198 1.4× 284 2.0× 27 0.3× 59 1.1× 21 685
Savithri Balasubramanian United States 8 356 0.9× 128 0.9× 71 0.5× 48 0.6× 19 0.4× 9 499
Julia Lopatnikova Russia 12 237 0.6× 137 1.0× 108 0.8× 30 0.4× 39 0.8× 57 419

Countries citing papers authored by Ke Geng

Since Specialization
Citations

This map shows the geographic impact of Ke Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Geng more than expected).

Fields of papers citing papers by Ke Geng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Geng. The network helps show where Ke Geng may publish in the future.

Co-authorship network of co-authors of Ke Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Geng. A scholar is included among the top collaborators of Ke Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Geng. Ke Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Liu, Yanhui, et al.. (2025). Eutrophication promoted the change of macrophyte community from R strategy to C strategy in Lake Taihu. Ecological Indicators. 174. 113484–113484.
2.
Patel, Ayushi S., Soumyadip Sahu, Ke Geng, et al.. (2024). Abstract 3916: TNG260, a small molecule CoREST inhibitor, sensitizes STK11-mutant NSCLC to anti-PD1 immunotherapy. Cancer Research. 84(6_Supplement). 3916–3916. 2 indexed citations
3.
Huang, Qingyuan, Fei Li, Hai Hu, et al.. (2022). Loss of TSC1/TSC2 sensitizes immune checkpoint blockade in non–small cell lung cancer. Science Advances. 8(5). eabi9533–eabi9533. 24 indexed citations
4.
5.
Calianese, David, Canan Kasikara, Viralkumar Davra, et al.. (2021). Phosphatidylserine-Targeting Monoclonal Antibodies Exhibit Distinct Biochemical and Cellular Effects on Anti-CD3/CD28–Stimulated T Cell IFN-γ and TNF-α Production. The Journal of Immunology. 207(2). 436–448. 2 indexed citations
6.
Davra, Viralkumar, Sushil Kumar, Ke Geng, et al.. (2020). Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity. Cancer Research. 81(3). 698–712. 61 indexed citations
7.
Geng, Ke. (2020). Post-translational modifications of the ligands: Requirement for TAM receptor activation. International review of cell and molecular biology. 357. 35–55. 5 indexed citations
8.
Davra, Viralkumar, Tamjeed Saleh, Ke Geng, et al.. (2020). Cyclophilin A Inhibitor Debio-025 Targets Crk, Reduces Metastasis, and Induces Tumor Immunogenicity in Breast Cancer. Molecular Cancer Research. 18(8). 1189–1201. 15 indexed citations
9.
Kasikara, Canan, Viralkumar Davra, David Calianese, et al.. (2019). Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti–PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer. Cancer Research. 79(10). 2669–2683. 93 indexed citations
10.
Geng, Ke, Sushil Kumar, Stanley Kimani, et al.. (2017). Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6. Frontiers in Immunology. 8. 1521–1521. 69 indexed citations
11.
Kumar, Sushil, Viralkumar Davra, Alison E. Obr, et al.. (2017). Crk adaptor protein promotes PD-L1 expression, EMT and immune evasion in a murine model of triple-negative breast cancer. OncoImmunology. 7(1). e1376155–e1376155. 40 indexed citations
12.
Kasikara, Canan, Sushil Kumar, Stanley Kimani, et al.. (2017). Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression. Molecular Cancer Research. 15(6). 753–764. 105 indexed citations
13.
Kimani, Stanley, Sushil Kumar, Viralkumar Davra, et al.. (2016). Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase. Cell Communication and Signaling. 14(1). 19–19. 25 indexed citations
14.
Kimani, Stanley, Ke Geng, Canan Kasikara, et al.. (2014). Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity. Frontiers in Immunology. 5. 566–566. 56 indexed citations
15.
Geng, Ke, et al.. (1998). Induction of Lactoferrin Expression in Murine ES Cells by Retinoic Acid and Estrogen. Experimental Cell Research. 245(1). 214–220. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026